Current Status of Clinical Application of Point-of-Care Testing
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Context.—: The clinical applications of point-of-care testing (POCT) are gradually increasing in many health care systems. Recently, POCT devices using molecular genetic method techniques have been developed. We need to examine clinical pathways to see where POCT can be applied to improve them. Objective.—: To introduce up-to-date POCT items and equipment and to provide the content that should be prepared for clinical application of POCT. Data Sources.—: Literature review based on PubMed searches containing the terms point-of-care testing, clinical chemistry, diagnostic hematology, and clinical microbiology. Conclusions.—: If medical resources are limited, POCT can help clinicians make quick medical decisions. As POCT technology improves and menus expand, areas where POCT can be applied will also increase. We need to understand the limitations of POCT so that it can be optimally used to improve patient management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
Antibody responses to SARS-CoV-2 in patients with COVID-19
Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876 · cited 1×
“Serologic testing may be helpful for diagnosis of suspected patients with negative reverse transcription polymerase chain reaction results and for identification of individuals with an adaptive immune response to severe acute respiratory syndrome coronavirus 2, indicating recent or prior infection.(118) But the POC im…”
Apple, F. S., Sandoval, Y., Jaffe, A. S., & Ordonez-Llanos, J. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.255109 · Cited by 408
Lenters-Westra, E., & Slingerland, R. J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.130641 · Cited by 228 · cited 1×
“2% for 6 POC instruments (DCA Vantage, Siemens Diagnostics; In2it, Bio-Rad; Afinion, Axis-Shield; Nycocard, Axis-Shield; Clover, Infopia; and InnovaStar, DiaSys).(48) According to data of 6 years of accuracy-based proficiency testing for HbA1c, POCT for HbA1c measurement showed the highest ‘‘unacceptable’’ rate and im…”
BackgroundVoormolen, D. N., DeVries, J. H., Sanson, R. M. E., Heringa, M. P., de Valk, H. W., Kok, M., van Loon, A. J., Hoogenberg, K., Bekedam, D. J., Brouwer, T. C. B., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13310 · Cited by 151
Hagen, A., Eichinger, A., Meyer-Buehn, M., Schober, T., & Huebner, J. (2020) · BMC Pediatrics · doi:10.1186/s12887-020-1944-2 · Cited by 41
Evaluation of Three Hemoglobin A1c Point-of-Care Instruments
Criel, M., Jonckheere, S., & Langlois, M. (2016) · Clinical Laboratory · doi:10.7754/clin.lab.2015.150301 · Cited by 9
Research works printed but not linked: 112
- Kankaanpaa M, Raitakari M, Muukkonen L, et al. Use of point-of-care testing and early assessment model reduces length of stay for ambulatory patients in an emergency department. Scand J Trauma Resusc Emerg Med. 2016; 24(1): 125. · DOI · Paper page
- Abel G. Current status and future prospects of point-of-care testing around the globe. Expert Rev Mol Diagn. 2015; 15(7): 853– 855. · DOI
- Abbasi U, Chowdhury P, Subramaniam S, et al. A cartridge based point-of-care device for complete blood count. Sci Rep. 2019; 9(1): 18583. · DOI
- Smith S, Madzivhandila P, Sewart R, et al. Microfluidic cartridges for automated, point-of-care blood cell counting. SLAS Technol. 2017; 22(2): 176– 185. · doi:10.1177/2211068216677820
- Larsson A, Carlsson L, Karlsson B, Lipcsey M. Rapid testing of red blood cell parameters in primary care patients using HemoScreen point of care instrument. BMC Fam Pract. 2019; 20(1): 77. · DOI
- Lingervelder D, Koffijberg H, Kusters R, IJzerman MJ. Point-of-care testing in primary care: a systematic review on implementation aspects addressed in test evaluations. Int J Clin Pract. 2019; 73(10): e13392. · DOI
- Heneghan C, Ward A, Perera R, et al. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet. 2012; 379(9813): 322– 334. · DOI · Paper page
- Crawford F, Andras A, Welch K, Sheares K, Keeling D, Chappell FM. D-dimer test for excluding the diagnosis of pulmonary embolism. Cochrane Database Syst Rev.2016(8):CD010864. · DOI · Paper page
- Marquardt U, Apau D. Point-of-care D-dimer testing in emergency departments. Emerg Nurse. 2015; 23(5): 29– 35. · DOI
- Sen B, Kesteven P, Avery P. Comparison of D-dimer point of care test (POCT) against current laboratory test in patients with suspected venous thromboembolism (VTE) presenting to the emergency department (ED). J Clin Pathol. 2014; 67(5): 437– 440. · DOI
- Perveen S, Unwin D, Shetty AL. Point of care D-dimer testing in the emergency department: a bioequivalence study. Ann Lab Med. 2013; 33(1): 34– 38. · DOI
- Lee-Lewandrowski E, Nichols J, Van Cott E, et al. Implementation of a rapid whole blood D-dimer test in the emergency department of an urban academic medical center: impact on ED length of stay and ancillary test utilization. Am J Clin Pathol. 2009; 132(3): 326– 331. · DOI · Paper page
- Lucassen WA, Erkens PM, Geersing GJ, et al. Qualitative point-of-care D-dimer testing compared with quantitative D-dimer testing in excluding pulmonary embolism in primary care. J Thromb Haemost. 2015; 13(6): 1004– 1009. · doi:10.1111/jth.12951
- Reynolds TM, Pillay TS. Rumsfeld Donald and point-of-care testing (POCT): the problem of unknown unknowns—venous blood and glucose oxidase-based test strips. J Clin Pathol. 2016; 69(10): 839– 840. · DOI
- Nathan DM, Genuth S, Lachin J, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14): 977– 986. · DOI · Paper page
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet. 1998; 352(9131): 837– 853. · DOI · Paper page
- Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345(19): 1359– 1367. · DOI · Paper page
- Petersen JR, Graves DF, Tacker DH, Okorodudu AO, Mohammad AA, Cardenas VJ Jr. Comparison of POCT and central laboratory blood glucose results using arterial, capillary, and venous samples from MICU patients on a tight glycemic protocol. Clin Chim Acta. 2008; 396(1–2): 10– 13. · DOI
- Shearer A, Boehmer M, Closs M, et al. Comparison of glucose point-of-care values with laboratory values in critically ill patients. Am J Crit Care. 2009; 18(3): 224– 230. · DOI
- Janssen K, Delanghe J. Importance of the pre-analytical phase in blood glucose analysis. Acta Clin Belg. 2010; 65(5): 311– 318. · DOI
- Karon BS, Blanshan CT, Deobald GR, Wockenfus AM. Retrospective evaluation of the accuracy of Roche AccuChek Inform and Nova StatStrip glucose meters when used on critically ill patients. Diabetes Technol Ther. 2014; 16(12): 828– 832. · DOI · Paper page
- Raizman JE, Shea J, Daly CH, et al. Clinical impact of improved point-of-care glucose monitoring in neonatal intensive care using Nova StatStrip: evidence for improved accuracy, better sensitivity, and reduced test utilization. Clin Biochem. 2016; 49(12): 879– 884. · DOI
- Lockyer MG, Fu K, Edwards RM, et al. Evaluation of the Nova StatStrip glucometer in a pediatric hospital setting. Clin Biochem. 2014; 47(9): 840– 843. · DOI
- Honiden S, Inzucchi SE. Metabolic management during critical illness: glycemic control in the ICU. Semin Respir Crit Care Med. 2015; 36(6): 859– 869. · DOI
- Brady V. Management of hyperglycemia in the intensive care unit: when glucose reaches critical levels. Crit Care Nurs Clin North Am. 2013; 25(1): 7– 13. · DOI
- Strasma PJ, Finfer S, Flower O, et al. Use of an intravascular fluorescent continuous glucose sensor in ICU patients. J Diabetes Sci Technol. 2015; 9(4): 762– 770. · DOI
- Christiansen MP, Klaff LJ, Brazg R, et al. A prospective multicenter evaluation of the accuracy of a novel implanted continuous glucose sensor: PRECISE II. Diabetes Technol Ther. 2018; 20(3): 197– 206. · DOI · Paper page
- Christiansen MP, Klaff LJ, Bailey TS, Brazg R, Carlson G, Tweden KS. A prospective multicenter evaluation of the accuracy and safety of an implanted continuous glucose sensor: the PRECISION study. Diabetes Technol Ther. 2019; 21(5): 231– 237. · DOI · Paper page
- Feig DS, Murphy HR. Continuous glucose monitoring in pregnant women with type 1 diabetes: benefits for mothers, using pumps or pens, and their babies. Diabet Med. 2018; 35(4): 430– 435. · DOI
- Florkowski C, Crooke M. Standardisation of reporting haemoglobin A1c: adoption of the New Zealand Society for the Study of Diabetes (NZSSD) position statement. N Z Med J. 2010; 123(1310): 43– 49.
- Maesa JM, Fernandez-Riejos P, Gonzalez-Rodriguez C, Sanchez-Margalet V. Screening for gestational diabetes mellitus by measuring glycated hemoglobin can reduce the use of the glucose challenge test. Ann Lab Med. 2019; 39(6): 524– 529. · DOI
- Miller CD, Barnes CS, Phillips LS, et al. Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care. 2003; 26(4): 1158– 1163. · DOI · Paper page
- Schnell O, Crocker JB, Weng J. Impact of HbA1c testing at point of care on diabetes management. J Diabetes Sci Technol. 2017; 11(3): 611– 617. · DOI · Paper page
- Al-Ansary L, Farmer A, Hirst J, et al. Point-of-care testing for Hb A1c in the management of diabetes: a systematic review and metaanalysis. Clin Chem. 2011; 57(4): 568– 576. · DOI · Paper page
- Thaler LM, Ziemer DC, Gallina DL, et al. Diabetes in urban African-Americans, XVII: availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care. 1999; 22(9): 1415– 1421. · DOI · Paper page
- Egbunike V, Gerard S. The impact of point-of-care A1C testing on provider compliance and A1C levels in a primary setting. Diabetes Educ. 2013; 39(1): 66– 73. · DOI
- Rust G, Gailor M, Daniels E, McMillan-Persaud B, Strothers H, Mayberry R. Point of care testing to improve glycemic control. Int J Health Care Qual Assur. 2008; 21(3): 325– 335. · DOI
- Laurence CO, Gialamas A, Bubner T, et al. Patient satisfaction with point-of-care testing in general practice. Br J Gen Pract. 2010; 60(572): e98– e104. · DOI
- Crocker JB, Lee-Lewandrowski E, Lewandrowski N, Baron J, Gregory K, Lewandrowski K. Implementation of point-of-care testing in an ambulatory practice of an academic medical center. Am J Clin Pathol. 2014; 142(5): 640– 646. · DOI
- Lee-Lewandrowski E, Lewandrowski K. Perspectives on cost and outcomes for point-of-care testing. Clin Lab Med. 2009; 29(3): 479– 489. · DOI
- Laurence CO, Moss JR, Briggs NE, Beilby JJ. The cost-effectiveness of point of care testing in a general practice setting: results from a randomised controlled trial. BMC Health Serv Res. 2010; 10: 165. · DOI · Paper page
- Chadee A, Blackhouse G, Goeree R. Point-of-care hemoglobin A1c testing: a budget impact analysis. Ont Health Technol Assess Ser. 2014; 14(9): 1– 23.
- Lenters-Westra E, Slingerland RJ. Three of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria. Clin Chem. 2014; 60(8): 1062– 1072. · DOI · Paper page
- Lenters-Westra E, English E. Evaluation of four HbA1c point-of-care devices using international quality targets: are they fit for the purpose? J Diabetes Sci Technol . 2018; 12(4): 762– 770. · DOI
- Chung S, Jun SH, Song WH, Song J. Six years' experience of accuracy-based proficiency testing for HbA1c in Korea. Journal of Laboratory Medicine and Quality Assurance. 2015; 37(2): 92– 100. · DOI
- Solvik UO, Bjelkaroy WI, Berg KVD, Saga AL, Hager HB, Sandberg S. Intensive educational efforts combined with external quality assessment improve the preanalytical phase in general practitioner offices and nursing homes. Clin Chem Lab Med. 2017; 55(12): 1857– 1864. · DOI
- Regan B, Boyle F, O'Kennedy R, Collins D. Evaluation of molecularly imprinted polymers for point-of-care testing for cardiovascular disease. Sensors (Basel). 2019; 19(16). · DOI
- Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018; 138(20): e618– e651.
- Bingisser R, Cairns C, Christ M, et al. Cardiac troponin: a critical review of the case for point-of-care testing in the ED. Am J Emerg Med. 2012; 30(8): 1639– 1649. · DOI
- Florkowski C, Don-Wauchope A, Gimenez N, Rodriguez-Capote K, Wils J, Zemlin A. Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM)—does it leverage any advantage in clinical decision making? Crit Rev Clin Lab Sci . 2017; 54(7–8): 471– 494. · DOI · Paper page
- Peacock WF, Diercks D, Birkhahn R, et al. Can a point-of-care Troponin I Assay be as good as a central laboratory assay?: a MIDAS investigation. Ann Lab Med. 2016; 36(5): 405– 412. · doi:10.3343/alm.2016.36.5.405
- Collinson P, Goodacre S, Gaze D, Gray A. Very early diagnosis of chest pain by point-of-care testing: comparison of the diagnostic efficiency of a panel of cardiac biomarkers compared with troponin measurement alone in the RATPAC trial. Heart. 2012; 98(4): 312– 318. · DOI
- Vafaie M, Biener M, Mueller M, et al. Addition of copeptin improves diagnostic performance of point-of-care testing (POCT) for cardiac troponin T in early rule-out of myocardial infarction—a pilot study. Int J Cardiol. 2015; 198: 26– 30. · DOI
- Bingisser R, Cairns CB, Christ M, et al. Measurement of natriuretic peptides at the point of care in the emergency and ambulatory setting: current status and future perspectives. Am Heart J. 2013; 166(4): 614– 621.e611. · DOI
- Iwaz JA, Maisel AS. Recent advances in point-of-care testing for natriuretic peptides: potential impact on heart failure diagnosis and management. Expert Rev Mol Diagn. 2016; 16(6): 641– 650. · DOI
- Bogaert L, Schiemsky T, Van Hover P, De Schrijver P, Van Hoovels L. Analytical and diagnostic performance evaluation of five creatinine POCT devices in the identification of patients at risk for post-contrast acute kidney injury (PCAKI). Clin Chem Lab Med. 2019; 57(9): e214– e217. · doi:10.1515/cclm-2018-1105
- Snaith B, Harris MA, Shinkins B, Jordaan M, Messenger M, Lewington A. Point-of-care creatinine testing for kidney function measurement prior to contrast-enhanced diagnostic imaging: evaluation of the performance of three systems for clinical utility. Clin Chem Lab Med. 2018; 56(8): 1269– 1276. · DOI
- van der Heijden C, Roosens L, Cluckers H, Van Craenenbroeck AH, Peeters B. Analytical and clinical performance of three hand-held point-of-care creatinine analyzers for renal function measurements prior to contrast-enhanced imaging. Clin Chim Acta. 2019; 497: 13– 19. · DOI
- Niska R, Bhuiya F, Xu J. National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary. Natl Health Stat Report. 2010;(26):1–31. · DOI · Paper page
- Braunstein GD. The long gestation of the modern home pregnancy test. Clin Chem. 2014; 60(1): 18– 21. · doi:10.1373/clinchem.2013.202655
- Nerenz RD, Song H, Gronowski AM. Screening method to evaluate point-of-care human chorionic gonadotropin (hCG) devices for susceptibility to the hook effect by hCG beta core fragment: evaluation of 11 devices. Clin Chem. 2014; 60(4): 667– 674. · DOI
- Nerenz RD, Gronowski AM. Point-of-care and over-the-counter qualitative human chorionic gonadotropin (hCG) devices remain susceptible to false-negative results caused by excess hCG beta core fragment. Clin Chem. 2013; 59(11): 1672– 1674. · doi:10.1373/clinchem.2013.212795
- Gronowski AM, Powers M, Stenman UH, Ashby L, Scott MG. False-negative results from point-of-care qualitative human chorionic gonadotropin (hCG) devices caused by excess hCGbeta core fragment vary with device lot number. Clin Chem. 2009; 55(10): 1885– 1886. · doi:10.1373/clinchem.2009.133280
- Gronowski AM, Cervinski M, Stenman UH, Woodworth A, Ashby L, Scott MG. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment. Clin Chem. 2009; 55(7): 1389– 1394. · DOI
- Griffey RT, Trent CJ, Bavolek RA, Keeperman JB, Sampson C, Poirier RF. “Hook-like effect” causes false-negative point-of-care urine pregnancy testing in emergency patients. J Emerg Med. 2013; 44(1): 155– 160. · doi:10.1016/j.jemermed.2011.05.032
- Nickmans S, Vermeersch P, Van Eldere J, Billen J. Performance of qualitative urinary hCG assays. Acta Clin Belg. 2014; 69(4): 277– 279. · doi:10.1179/0001551214z.00000000069
- Greene DN, Schmidt RL, Kamer SM, Grenache DG, Hoke C, Lorey TS. Limitations in qualitative point of care hCG tests for detecting early pregnancy. Clin Chim Acta. 2013; 415: 317– 321. · DOI
- Terwijn M, van Schie A, Blankenstein MA, Heijboer AC. Pregnancy detection by quantitative urine hCG analysis: the need for a lower cut-off. Clin Chim Acta. 2013; 424: 174. · doi:10.1016/j.cca.2013.06.010
- Kamer SM, Foley KF, Schmidt RL, Greene DN. Analytical sensitivity of four commonly used hCG point of care devices. Clin Biochem. 2015; 48(6): 448– 452. · doi:10.1016/j.clinbiochem.2014.12.015
- Tenenbein M. Do you really need that emergency drug screen? Clin Toxicol (Phila) . 2009; 47(4): 286– 291. · DOI
- Mastrovitch TA, Bithoney WG, DeBari VA, Nina AG. Point-of-care testing for drugs of abuse in an urban emergency department. Ann Clin Lab Sci. 2002; 32(4): 383– 386.
- Attema-de Jonge ME, Peeters SY, Franssen EJ. Performance of three point-of-care urinalysis test devices for drugs of abuse and therapeutic drugs applied in the emergency department. J Emerg Med. 2012; 42(6): 682– 691. · DOI
- Tomaszewski C, Runge J, Gibbs M, Colucciello S, Price M. Evaluation of a rapid bedside toxicology screen in patients suspected of drug toxicity. J Emerg Med. 2005; 28(4): 389– 394. · DOI
- Zhang Y, Kwong TC. Utilization management in toxicology. Clin Chim Acta. 2014; 427: 158– 166. · DOI
- Wiencek JR, Colby JM, Nichols JH. Rapid assessment of drugs of abuse. Adv Clin Chem. 2017; 80: 193– 225. · DOI
- Wang LL, Ren XX, He Y, Cui GF, Wei ZW, Yun KM. An experimental pharmacokinetics study of diazepam and its metabolites in oral fluid of Chinese population [published online January 21, 2020]. J Anal Toxicol. doi:10.1093/jat/bkz101 · DOI
- Scherer JN, Fiorentin TR, Borille BT, et al. Reliability of point-of-collection testing devices for drugs of abuse in oral fluid: a systematic review and meta-analysis. J Pharm Biomed Anal. 2017; 143: 77– 85. · DOI
- Wagmann L, Maurer HH. Bioanalytical methods for new psychoactive substances. Handb Exp Pharmacol. 2018; 252: 413– 439. · DOI
- Nichols JH, Christenson RH, Clarke W, et al. Executive summary: the National Academy of Clinical Biochemistry Laboratory Medicine Practice Guideline: evidence-based practice for point-of-care testing. Clin Chim Acta. 2007; 379(1–2): 14– 28; discussion 29–30. · doi:10.1016/j.cca.2006.12.027
- Zeserson E, Goodgame B, Hess JD, et al. Correlation of venous blood gas and pulse oximetry with arterial blood gas in the undifferentiated critically ill patient. J Intensive Care Med. 2018; 33(3): 176– 181. · DOI
- Schrauben SJ, Negoianu D, Costa C, et al. Accuracy of acid-base diagnoses using the central venous blood gas in the medical intensive care unit. Nephron. 2018; 139(4): 293– 298. · doi:10.1159/000488501
- Ekstrom M, Engblom A, Ilic A, Holthius N, Nordstrom P, Vaara I. Calculated arterial blood gas values from a venous sample and pulse oximetry: clinical validation. PLoS One. 2019; 14(4): e0215413. · DOI
- Mirzazadeh M, Morovat A, James T, Smith I, Kirby J, Shine B. Point-of-care testing of electrolytes and calcium using blood gas analysers: it is time we trusted the results. Emerg Med J. 2016; 33(3): 181– 186. · DOI · Paper page
- Triplett KE, Wibrow BA, Norman R, et al. Can the blood gas analyser results be believed? A prospective multicentre study comparing haemoglobin, sodium and potassium measurements by blood gas analysers and laboratory auto-analysers. Anaesth Intensive Care. 2019; 47(2): 120– 127. · DOI
- Gibbons M, Klim S, Mantzaris A, Dillon O, Kelly AM. How closely do blood gas electrolytes and haemoglobin agree with serum values in adult emergency department patients: an observational study. Emerg Med Australas. 2019; 31(2): 241– 246. · DOI
- Kankaanpaa M, Holma-Eriksson M, Kapanen S, et al. Comparison of the use of comprehensive point-of-care test panel to conventional laboratory process in emergency department. BMC Emerg Med. 2018; 18(1): 43. · DOI
- Van den Bruel A, Thompson MJ, Haj-Hassan T, et al. Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review. BMJ. 2011; 342:d3082. · DOI · Paper page
- Chaisson LH, Semitala FC, Asege L, et al. Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy. AIDS. 2019; 33(5): 895– 902. · DOI
- Brouwer N, van Pelt J. Validation and evaluation of eight commercially available point of care CRP methods. Clin Chim Acta. 2015; 439: 195– 201. · DOI
- Na JY, Park JT. Evaluation of point-of-care testing for C-reactive protein in forensic medicine. J Korean Med Sci. 2019; 34(38): e246. · doi:10.3346/jkms.2019.34.e246
- Thaler M, Luppa PB. Highly sensitive immunodiagnostics at the point of care employing alternative recognition elements and smartphones: hype, trend, or revolution? Anal Bioanal Chem . 2019; 411(29): 7623– 7635. · DOI
- Bulterys MA, Wagner B, Redard-Jacot M, et al. Point-of-care urine LAM tests for tuberculosis diagnosis: a status update [published online December 31, 2019]. J Clin Med. 2020; 9(1): 111. doi:10.3390/jcm9010111 · DOI · Paper page
- Kim H, Chung DR, Kang M. A new point-of-care test for the diagnosis of infectious diseases based on multiplex lateral flow immunoassays. Analyst. 2019; 144(8): 2460– 2466. · DOI · Paper page
- Qin Q, Wang K, Yang J, et al. Algorithms for immunochromatographic assay: review and impact on future application. Analyst. 2019; 144(19): 5659– 5676. · DOI
- Egilmezer E, Walker GJ, Bakthavathsalam P, et al. Systematic review of the impact of point-of-care testing for influenza on the outcomes of patients with acute respiratory tract infection. Rev Med Virol. 2018; 28(5): e1995. · DOI · Paper page
- Popowitch EB, Miller MB. Performance characteristics of Xpert Flu/RSV XC assay. J Clin Microbiol. 2015; 53(8): 2720– 2721. · doi:10.1128/jcm.00972-15
- Wahrenbrock MG, Matushek S, Boonlayangoor S, Tesic V, Beavis KG, Charnot-Katsikas A. Comparison of Cepheid Xpert Flu/RSV XC and BioFire FilmArray for detection of influenza A, influenza B, and respiratory syncytial virus. J Clin Microbiol. 2016; 54(7): 1902– 1903. · DOI
- Nitsch-Osuch A, Kuchar E, Golebiak I, Kanecki K, Tarka P, Brydak LB. Rapid influenza diagnostic tests improve suitability of antiviral treatment in hospitalized children. Adv Exp Med Biol. 2017; 968: 1– 6. · doi:10.1007/5584_2016_181
- Brendish NJ, Malachira AK, Armstrong L, et al. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med. 2017; 5(5): 401– 411. · DOI · Paper page
- Li-Kim-Moy J, Dastouri F, Rashid H, et al. Utility of early influenza diagnosis through point-of-care testing in children presenting to an emergency department. J Paediatr Child Health. 2016; 52(4): 422– 429. · doi:10.1111/jpc.13092
- Brendish NJ, Schiff HF, Clark TW. Point-of-care testing for respiratory viruses in adults: the current landscape and future potential. J Infect. 2015; 71(5): 501– 510. · DOI
- Brendish NJ, Mills S, Ewings S, Clark TW. Impact of point-of-care testing for respiratory viruses on antibiotic use in adults with exacerbation of airways disease. J Infect. 2019; 79(4): 357– 362. · doi:10.1016/j.jinf.2019.06.010
- Chavez PR, Bradley HM, Wesolowski LG, et al. Performance evaluation of four point-of-care HIV tests using unprocessed specimens. J Clin Virol. 2020; 124: 104282. · doi:10.1016/j.jcv.2020.104282
- Pai NP, Tulsky JP, Cohan D, Colford JM Jr, Reingold AL. Rapid point-of-care HIV testing in pregnant women: a systematic review and meta-analysis. Trop Med Int Health. 2007; 12(2): 162– 173. · DOI · Paper page
- Dalcin D, Bogoch II. Point-of-care testing for HIV. CMAJ. 2018; 190(18): E569. · DOI
- Gliddon HD, Peeling RW, Kamb ML, Toskin I, Wi TE, Taylor MM. A systematic review and meta-analysis of studies evaluating the performance and operational characteristics of dual point-of-care tests for HIV and syphilis. Sex Transm Infect. 2017; 93(S4): S3– S15. · DOI · Paper page
- Negedu-Momoh OR, Jegede FE, Yakubu A, et al. Performance evaluation of BD FACSPresto point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria. PLoS One. 2017; 12(5): e0178037. · doi:10.1371/journal.pone.0178037
- Moran Z, Sacks JA, Frimpong FK, Frimpong AB, Ben Amor Y. Performance of the BD-FACS Presto for CD4 count and hemoglobin measurement in a district hospital and rural laboratory in Ghana. PLoS One. 2019; 14(2): e0212684. · doi:10.1371/journal.pone.0212684
- Bwana P, Vojnov L, Adhiambo M, et al. The BD FACSPresto point of care CD4 test accurately enumerates CD4+ T cell counts. PLoS One. 2015; 10(12): e0145586. · DOI
- Hong KH, Lee SW, Kim TS, et al. Guidelines for laboratory diagnosis of coronavirus disease 2019 (COVID-19) in Korea. Ann Lab Med. 2020; 40(5): 351– 360. · DOI · Paper page
- Imai K, Tabata S, Ikeda M, et al. Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19. J Clin Virol. 2020; 128: 104393. · DOI
- Brendish NJ, Malachira AK, Clark TW. Molecular point-of-care testing for respiratory viruses versus routine clinical care in adults with acute respiratory illness presenting to secondary care: a pragmatic randomised controlled trial protocol (ResPOC). BMC Infect Dis. 2017; 17(1): 128. · DOI
Metadata
- Authors
- Park, H.-D.
- Venue
- Archives of Pathology & Laboratory Medicine
- Published
- 2020-10-14
- Volume
- 145
- Issue
- 2
- Pages
- 168-175
- ISSN
- 1543-2165
- 0003-9985
- Cited by
- 49
- References
- 8
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current Status of Clinical Application of Point-of-Care Testing. https://app.cochat.ai/papers/10.5858/arpa.2020-0112-ra
- The paper
- Park, H.-D. (2021). Current Status of Clinical Application of Point-of-Care Testing. Archives of Pathology & Laboratory Medicine. https://doi.org/10.5858/arpa.2020-0112-ra
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.